Growth Factor Treatment Did Not Boost Results With Node Transfer for Lymphedema

May Be Interested In:Vancouver: Suspect named in deadly Lapu Lapu festival attack



(MedPage Today) — A growth factor-stimulating gene therapy did not improve outcomes with vascularized lymph node transfer (VLNT) for breast cancer-related lymphedema in a small randomized trial, that added to evidence of VLNT safety and efficacy…

share Share facebook pinterest whatsapp x print

Similar Content

2024 Set To Break Temperature Records And Become Hottest Year Ever, Surpassing 1.5°C Threshold
2024 Set To Break Temperature Records And Become Hottest Year Ever, Surpassing 1.5°C Threshold
Trump accuse Trudeau d’utiliser les tarifs pour «rester au pouvoir»: les deux hommes se sont parlé 50 minutes
Trump accuse Trudeau d’utiliser les tarifs pour «rester au pouvoir»: les deux hommes se sont parlé 50 minutes
Infosys work-from-home policy: Narayana Murthy-led IT major issues clarification on ‘system intervention’ for attendance | Company Business News
Infosys work-from-home policy: Narayana Murthy-led IT major issues clarification on ‘system intervention’ for attendance | Company Business News
Google News
Google News
The Who, Royal Albert Hall, London, March 27, 2025
The Who, Royal Albert Hall, London, March 27, 2025
'Morrison Hotel' made famous by The Doors goes up in flames in LA
‘Morrison Hotel’ made famous by The Doors goes up in flames in LA
Unscripted News: Where Reality Hits Hard | © 2025 | Daily News